Table 1 Patient characteristics (laboratory data obtained on the day of Seraph® treatment)
# 1 | # 2 | # 3 | # 4 | # 5 | # 6 | # 7 | |
|---|---|---|---|---|---|---|---|
Gender | M | F | M | M | F | M | M |
Age (years | 77 | 78 | 54 | 41 | 61 | 65 | 72 |
Weight (kg) | 76.5 | 75 | 107 | 119 | 122 | 60.5 | 71 |
Height (cm) | 164 | 160 | 188 | 180 | 168 | 166 | 175 |
Onset of symptoms-Seraph treatment (d) | 5 | 19 | 10 | 13 | 9 | 16 | 12 |
Died @ hospital day | 60 | 9 | 7 | Survivor | Survivor | Survivor | 18 |
N-protein before Seraph therapy (pg/mL) | 1021.3 | 26.6 | 121,884.2 | 1070.2 | 1036.5 | 19.5 | - |
N-protein after Seraph therapy (pg/mL) | 769.6 | 24.1 | 111,035.2 | 931.5 | 376.2 | 12.1 | - |
CRP (mg/l) | 73 | 443 | 87 | 110 | 156 | 129 | 39 |
Ferritin (ng/mL) | 2957 | 830 | 10,005 | 838 | 589 | 756 | 1,412 |
PCT (µg/L) | 0.7 | 18.5 | 4.4 | 1.1 | 0.1 | 0.1 | 0.1 |
D-dimer (mg/L) | 4.68 | 35.2 | 3.26 | 1.04 | 0.90 | 4.00 | 35.2 |
Therapy (h) | IHD (4) | CRRT (24) | IHD (4) | IHD (5) | HP (15) | HP (4) | HP (14) |
Qb (mL/min) | 300 | 90 | 250 | 250 | 80 | 200 | 100 |